Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Keymed Biosciences (2162 HK)
Watchlist
67
Analysis
Health Care
•
Hong Kong
Keymed Biosciences Inc. operates a biotechnology company. The Company focus on the in-house discovery and development of innovative biological therapies. Keymed Biosciences provides services in China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Keymed Biosciences
•
22 Sep 2024 09:43
China Healthcare Weekly (Sep.22) - CR Sanjiu's Trouble, Weight-Loss Drug Market Saturation, Keymed
Anhui's VBP includes OTC TCM, challenging CR Sanjiu's pricing autonomy. There are concerns about weight-loss drug market saturation. CM310 missing...
Xinyao (Criss) Wang
Follow
379 Views
Share
bullish
•
Keymed Biosciences
•
15 Nov 2023 08:55
Keymed Biosciences (2162.HK) - Looking Forward to the Next Leap in Valuation
It's hard for Keymed's share price to rise significantly on its own unless there's an uptick in the entire biotech sector as a whole. Valuation...
Xinyao (Criss) Wang
Follow
347 Views
Share
bullish
•
Chongqing Taiji Industry (Group) A
•
04 Aug 2024 11:00
China Healthcare Weekly (Aug.4)- Taiji Group & China TCM, TCM Formula Granules VBP, Keymed's Trouble
Substitution of TCM formula granules for decoction pieces is a trend despite the VBP. Keymed will face difficulties without NRDL negotiation....
Xinyao (Criss) Wang
Follow
308 Views
Share
bearish
•
China Resources Medical
•
30 Jun 2024 15:56
China Healthcare Weekly (Jun.30) - TCM Companies Witness Soaring Costs, Rising Stars in ADC, 1515.HK
Investors should watch for rising TCM raw material prices. Chinese pharmaceutical companies are rising in ADC.Caution with China Resources...
Xinyao (Criss) Wang
Follow
373 Views
Share
bearish
•
YSB
•
23 Jun 2024 15:59
China Healthcare Weekly (Jun23)-Retail Pharmacy's Dilemma, Logic to Biotech's Stock Price,YSB's Risk
Retail pharmacies facing industry clearance due to negative policies.Biotech stock performance tied to sustainable development path. YSB faces...
Xinyao (Criss) Wang
Follow
351 Views
Share
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.39.3
x